Compare Lustrum:SDS Biotech K.K.:4952

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index SDS Biotech K.K. Go to web site 4952 Chemicals TSE March 1, 2000 2008.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

SDS Biotech K.K. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SDS Biotech K.K. Balance Sheet 2021年3月期 SDS Biotech K.K. Balance Sheet 2020年3月期 SDS Biotech K.K. Balance Sheet 2019年3月期 SDS Biotech K.K. Balance Sheet 2018年3月期 SDS Biotech K.K. Balance Sheet 2017年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017
Cash and Cash Equivalents
(Percent)
0
-
0
-
0
-
0
-
748
(4.1%)
Other Current AssetsHelp
(Percent)
10,849up
(71.3%)down
10,248up
(71.4%)up
8,245down
(60.4%)down
9,468down
(66.7%)down
12,425
(68.9%)
Tangible Fixed AssetsHelp
(Percent)
2,302up
(15.1%)down
2,262down
(15.8%)down
3,215up
(23.5%)up
2,251down
(15.9%)up
2,542
(14.1%)
Intangible Fixed AssetHelp
(Percent)
17down
(0.1%)down
27down
(0.2%)down
33down
(0.2%)down
50down
(0.4%)down
93
(0.5%)
Investments and OthersHelp
(Percent)
2,052up
(13.5%)up
1,814down
(12.6%)down
2,166down
(15.9%)down
2,418up
(17.0%)up
2,220
(12.3%)
Total AssetsHelp
(Percent)
15,220
(100%)
14,351
(100%)
13,659
(100%)
14,187
(100%)
18,027
(100%)
Total Current LiabilitiesHelp
(Percent)
4,387up
(28.8%)down
4,295up
(29.9%)up
3,986down
(29.2%)down
4,388down
(30.9%)down
8,679
(48.1%)
Total Long-term LiabilitiesHelp
(Percent)
2,844down
(18.7%)down
3,396down
(23.7%)down
3,851down
(28.2%)up
3,999up
(28.2%)up
3,061
(17.0%)
Shareholder's EquityHelp
(Percent)
7,989up
(52.5%)up
6,660up
(46.4%)up
5,822up
(42.6%)up
5,800down
(40.9%)up
6,288
(34.9%)
Total LiabilitiesHelp
(Percent)
15,220
(100%)
14,351
(100%)
13,659
(100%)
14,187
(100%)
18,027
(100%)

SDS Biotech K.K. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SDS Biotech K.K. Profit and Loss Account 2021年3月期 SDS Biotech K.K. Profit and Loss Account 2020年3月期 SDS Biotech K.K. Profit and Loss Account 2019年3月期 SDS Biotech K.K. Profit and Loss Account 2018年3月期 SDS Biotech K.K. Profit and Loss Account 2017年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017
Amount of Sales
(Percent)
12,000
(100%)
12,387
(100%)
11,585
(100%)
12,929
(100%)
14,988
(100%)
Total Sales
(Percent)
12,000
(100%)
12,387
(100%)
11,585
(100%)
12,929
(100%)
14,988
(100%)
Cost of SalesHelp
(Percent)
7,592down
(63.3%)down
8,254up
(66.6%)up
7,537down
(65.1%)up
8,275down
(64.0%)down
9,967
(66.5%)
Other Costs and RevenueHelp 3,036up
(25.3%)up
2,946down
(23.8%)down
3,657down
(31.6%)down
4,835down
(37.4%)up
5,225
(34.9%)
Total CostsHelp 10,628 11,200 11,194 13,109 15,192
Net RevenueHelp 4,408up
(36.7%)up
4,133up
(33.4%)down
4,048down
(34.9%)down
4,654down
(36.0%)up
5,021
(33.5%)
Earnings Before TaxHelp 1,832up
(15.3%)up
1,674up
(13.5%)up
574up
(5.0%)up
-467down
(-3.6%)down
-226
(-1.5%)
Net IncomeHelp 1,372up
(11.4%)up
1,188up
(9.6%)up
391up
(3.4%)up
-181up
(-1.4%)down
-204
(-1.4%)
当期純利益 1,372 1,188 391 -181 -204

SDS Biotech K.K. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SDS Biotech K.K. Cash Flow Statement 2021年3月期 SDS Biotech K.K. Cash Flow Statement 2020年3月期 SDS Biotech K.K. Cash Flow Statement 2019年3月期 SDS Biotech K.K. Cash Flow Statement 2018年3月期 SDS Biotech K.K. Cash Flow Statement 2017年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018 March 31, 2017
Operating Cash Flow(OFC)Help
(Percent)
1,989up
(100.0%)up
742down
(74.4%)up
762down
(39.2%)down
2,387up
(73.5%)up
-5
(-1.0%)
Investing Cash Flow(ICF)Help
(Percent)
-305down
(-15.3%)up
-229up
(-23.0%)up
-1,112up
(-57.2%)up
-2,467down
(-76.0%)down
-260
(-49.2%)
Financing Cash FlowHelp
(Percent)
-945down
(-47.5%)up
-764up
(-76.6%)down
-832down
(-42.8%)down
850up
(26.2%)up
-220
(-41.6%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
-7down
(-0.4%)up
-4down
(-0.4%)down
4down
(0.2%)down
9up
(0.3%)up
-43
(-8.2%)
Net Increase and Decrease in Cash and Cash Equivalentsn 732up
(36.8%)up
-256up
(-25.6%)up
-1,178down
(-60.6%)down
779up
(24.0%)up
-528
(-100.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

SDS Biotech K.K.
TOYODA GOSEI CO.,LTD.
MERCURY REALTECH INNOVATOR Inc.
SINKO INDUSTRIES LTD.
OKAMOTO INDUSTRIES, INC.

Company where related level is highHelp

TOYO DRILUBE CO.,LTD.
POLA ORBIS HOLDINGS INC.
MIRAI INDUSTRY CO.,LTD.
S.T.CORPORATION
Privee Turnaround Group Co.,Ltd.
KOATSU GAS KOGYO CO., LTD.
Nippon Shikizai,Inc.
FP CORPORATION
YASUHARA CHEMICAL CO.,LTD.
TOHCELLO Co.,Ltd.